| Compound |
Manufacturing Company |
Development Phase |
| T-1095 |
Tanabe |
Discontinued |
| TS-033 |
Taisho |
Discontinued |
| AVE2268 |
Sanofi-Aventis |
Discontinued |
| YM-543 |
Astellas/Kotobuki |
Discontinued |
| Remogliflozin |
GlaxoSmithKline |
Discontinued |
| Sergliflozin |
GlaxoSmithKline/Kissei |
Discontinued |
| Dapagliflozin |
Bristol-Myers Squibb/AstraZeneca |
Phase III |
| Canagliflozin |
JNJ/Mitsubishi Tanabe |
Phase III |
| BI 10773 |
BoehringerIngelheim |
Phase II |
| BI 44847 |
BoehringerIngelheim/Ajinomoto |
Phase II |
| R-7201 |
Roche/Chugai |
Phase II |
| TS-071 |
Taisho |
Phase II |
| LX4211 |
Lexicon |
Phase II |
|
